What is the Bredesen ReCode 3.0 protocol?
- Dr. Dale Bredesen’s ReCODE protocol evaluates 150 factors known to contribute to Alzheimer’s disease.
- Type 1 Alzheimer’s is primarily caused by inflammatory factors; type 2 involves atrophic responses; type 1.5 is a mix of inflammation and atrophy, and type 3 is primarily caused by toxic exposures
- Only 5 percent of Alzheimer’s cases are “familial” Alzheimer’s disease, a genetic condition that causes early onset Alzheimer’s, the rest are caused by lifestyle factors.
A personalized, comprehensive protocol for the reversal of cognitive decline in individuals with early Alzheimer’s disease, mild cognitive impairment (MCI), subjective cognitive impairment (SCI), or at risk for cognitive decline, developed by Dr. Bredesen,
Dr. Bredesen is internationally recognized as an expert in the mechanisms of Color version of Dale Bredesen board portraitneurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, NC. He served as Chief Resident in Neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding President and CEO.
Christi will be offering this protocol to eligible candidates Summer 2018. Stay tuned!
Enter your email below to stay in the loop!